We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIO™ Phase II Study

News   Mar 09, 2011

 
High Rates of Pathological Complete Response in Patients with Advanced Esophageal Cancer in OPAXIO™ Phase II Study
 
 
Advertisement
 

RELATED ARTICLES

Phase 1 Clinical Trial of University of Queensland COVID-19 Vaccine Begins

News

The first participants were enrolled into a Phase 1 clinical trial of the University of Queensland’s (UQ) COVID-19 vaccine candidate on July 13.

READ MORE

Breast Cancer Patients 60% More Likely To Die of Cancer After Surviving a Heart Attack

News

A new study reports that people with breast cancer are 60 percent more likely to die of cancer after surviving a heart attack.

READ MORE

Hydroxychloroquine Reduces Incidence of Heartbeat Condition in Newborns

News

Researchers show that giving the antimalarial drug hydroxychloroquine to pregnant women who previously had a child affected by congenital heart block reduced the likelihood that the condition recurred in a subsequent pregnancy by 50%.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE